Literature DB >> 7652813

Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma?

P Moreno1, E Jaurrieta, J Figueras, C Benasco, A Rafecas, J Fabregat, J Torras, T Casanovas, L Casais.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7652813

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization.

Authors:  Do Young Kim; Moon Seok Choi; Joon Hyoek Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Sung Wook Shin; Sung Wook Choo; Young Soo Do; Jong Chul Rhee
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

2.  Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.

Authors:  Yusuf Gunay; Necdet Guler; Onur Yaprak; Murat Dayangac; Murat Akyildiz; Gulum Altaca; Yildiray Yuzer; Yaman Tokat
Journal:  Indian J Surg       Date:  2014-04-24       Impact factor: 0.656

3.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

4.  Prediction of complete necrosis of hepatocellular carcinoma treated with transarterial chemoembolization prior to liver transplantation.

Authors:  Sue Jin Kim; Moon Seok Choi; Ja Young Kang; Dong Il Choi; Cheol Keun Park; Geum Youn Gwak; Joon Hyoek Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

5.  Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.

Authors:  Guang-Qin Xiao; Chang Liu; Da-Li Liu; Jia-Yin Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

6.  Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation.

Authors:  Gun Hyung Na; Dong Goo Kim; Jae Hyun Han; Eun Young Kim; Soo Ho Lee; Tae Ho Hong; Young Kyoung You
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 7.  Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma.

Authors:  Marc Najjar; Surbhi Agrawal; Jean C Emond; Karim J Halazun
Journal:  J Hepatocell Carcinoma       Date:  2018-01-18

8.  Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival.

Authors:  Aline L Chagas; Guilherme E G Felga; Marcio A Diniz; Renato F Silva; Angelo A Mattos; Rita C M A Silva; Ilka F S F Boin; José H P Garcia; Agnaldo S Lima; Julio C U Coelho; Paulo L Bittencourt; Venâncio A F Alves; Luiz A C D'Albuquerque; Flair J Carrilho
Journal:  Eur J Gastroenterol Hepatol       Date:  2019-09       Impact factor: 2.566

9.  Contemporary strategies in the management of hepatocellular carcinoma.

Authors:  Shirin Elizabeth Khorsandi; Nigel Heaton
Journal:  HPB Surg       Date:  2012-11-04

10.  Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.

Authors:  Yung Fong Tsai; Hsiu Pin Chen; Fu Chao Liu; Shih Hao Liu; Chun Yu Chen; Chih Wen Cheng; Jr-Rung Lin
Journal:  Oncotarget       Date:  2016-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.